Regeneron has won the first ever FDA approval for a gene therapy to treat a rare type of inherited hearing loss, and the company plans

The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.

Tempero Bio, a drug developer that had big ambitions to shake up the treatment of substance use disorders, is winding down operations, Endpoints News has

MAHA’s sway over HHS could face a fresh test now that President Trump has a new pick for CDC director: Erica Schwartz, a former deputy

The radioligand field is on the cusp of a major competitive moment, as a rival looks to bring the first generic to a market that’s